# A Study of Actonel for the Prevention of Bone Loss

> **NCT00452439** · PHASE3 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 72 (actual)

## Conditions studied

- Leukemia
- Lymphoma

## Interventions

- **DRUG:** Actonel (Risedronate)
- **DIETARY_SUPPLEMENT:** Calcium
- **DIETARY_SUPPLEMENT:** Vitamin D

## Key facts

- **NCT ID:** NCT00452439
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2020-12-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00452439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00452439, "A Study of Actonel for the Prevention of Bone Loss". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT00452439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*